Summary. ' 
Introduction
Centchroman (3,4-rr<ms-2,2-dimethyl-3-phenyl-4-p (ß-pyrrolidinoethoxy phenyl)-7-methoxy enro¬ man), a non-steroidal contraceptive being developed at this Institute, has been reported to induce 'tube-locking' of embryos at the ampullary-isthmic junction of the oviducts in mice, when admini¬ stered within 24 h of mating. The compound, however, did not seem to produce any deleterious effect on preimplantation embryonic development, except for some delay in cleavage rate, morula to blastocyst transformation and shedding of zona pellucida. Apparently normal embryos were recovered from the ampulla of centchroman-treated mice until Day 10 post coitum (Singh & Kamboj, 1981) . We have now investigated the viability and development of embryos 'tube-locked' after treatment with centchroman by surgical transfer of embryos recovered at different times to the uteri of untreated pseudopregnant females or to the sterile horn of unilaterally pregnant mice.
It is generally believed that preimplantation mammalian embryos are remarkably resistant to teratogens and after treatment during this period either die before implantation or survive to term without being malformed (Austin, 1973) . Earlier investigators have stressed the need for teratological evaluation of new compounds by treatment during the preimplantation period in addition to the conventional treatment during the period of organogénesis. In view of this, and the suggestion that the 'tube-locked' embryos might ultimately migrate to the uterus and implant (Humphrey, 1976) , the 'tube-locked' embryos developing until Day 19 of pregnancy in the foster mothers were assessed for any teratological anomalies.
Materials and Methods
Colony bred adult Swiss mice (20-30 g) of this Institute were maintained in air-conditioned quarters (22 ± 1°C) and in uniform husbandry conditions. The animals were kept in cages in groups of 5 and were given pellet diet (Hindustan Levers Ltd, Bombay) and tap water ad libitum.
Donor females mated to fertile male mice received one oral dose of 2 mg centchroman/kg body weight (Singh & Kamboj, 1981) (Cross & Brinster, 1970) , according to the procedure described earlier (Singh & Kamboj, 1981) . The medium was prepared before use with chemicals purchased from Sigma, St Louis, Missouri, U.S.A. and sterilized by passing through a sterile Millipore filter (pore size 0-45 pm). The pH of the medium was adjusted to about 7-4 with sterile 5% C02 in air. The embryos were washed 2-3 times with sterile medium before transfer. The required numbers of embryos were picked up in 0-2-0-5 µ of the medium, using a sterile glass micropipette attached to a 1 ml glass syringe through a small rubber tubing, and gently transferred into each uterine horn of an untreated pseudopregnant female through a small puncture made near its distal end with a sterile 24-gauge needle. When embryos were transferred into the sterile uterine horn of unilaterally pregnant mice, one uterine horn of each recipient had been ligated and incised near the uterotubal junction on Day 1 post coitum. In our experience, such mice do not normally exhibit implantations in the ligated horn. On average 4 embryos were transferred into each uterine horn. All manipulations were carried out under sterile conditions. The details of the numbers and age of the embryos transferred and of the recipients used are shown in Tables 1 & 2 (Sethi, 1977) 
Discussion
These results show that centchroman did affect the viability of mouse embryos. Little information is available in the literature on the viability and development of embryos 'tube-locked' in the ampulla by treatment with oestrogenic/antioestrogenic compounds. Viability of 'tube-locked' embryos recovered from oestradiol-treated mice on Day A post coitum was not affected (Humphrey, 1968) but there is no information for embryos retained in the ampulla for longer periods.
Blastocysts confined within the oviduct beyond Day 6 of pregnancy by placing a ligature at the utero-tubal junction failed to develop when transferred to the uteri of untreated pseudopregnant mice (Weitlauf, 1971) . In contrast, in the present study at least 17% of the embryos 'tube-locked' until Day 8 post coitum implanted when transferred to the uterus of suitable recipients ; and 25% of these developed normally to healthy fetuses. This difference might be due to the different sites of confinement of the embryos in the oviducts. In the centchroman-treated mice the embryos are always retained in the ampullary portion (Singh & Kamboj, 1981) ; but in ligated tubes, they migrate to proximal portion (loop 8) of the isthmus (Humphrey, 1968) , and this is not a site conducive to normal preimplantation embryonic development (Whittingham, 1968) . Moreover, while an apparent delay in cleavage rate, morula to blastocyst transformation and shedding of zona pellucida has been demonstrated for embryos 'tube-locked' in response to oestrogenic compounds (Humphrey & Martin, 1968; Humphrey, 1968; Singh & Kamboj, 1981) , no such delay in develop¬ ment was observed when embryos were retained in the oviducts by ligation (Humphrey & Martin, 1968) . In contrast, embryos recovered from ligated oviducts have been reported to possess relatively high metabolic activity (Weitlauf, 1971) . Whether the dormant condition of the 'tubelocked' embryos of centchroman-treated mice in any way protects them from damage, as has been suggested for the dormant uterine embryos of mice undergoing experimentally induced delay of implantation (Weitlauf, 1971) , is, however, not known. Pertinently, the diapausing uterine blasto¬ cysts of mouse have been reported to remain viable for as long as 25 days (Weitlauf & Greenwald, 1968) .
It is important to determine whether the depressed pregnancy and implantation rates and the increased résorption rate observed after transfer of the 'tube-locked' embryos in this study were due only to their prolonged confinement in the ampulla or were associated with a direct effect of the compound on the embryos. It is not known whether compounds like centchroman actually enter the lumen of the genital tract in quantities sufficient to affect embryonic development. In the rat, in which 'tube-locking' of the embryos does not occur (Blye, 1970) , centchroman induces a situation akin to delayed implantation and the embryos, which remain in utero in a viable condition, implant after exogenous oestrogen and progesterone treatment (Kamboj, Setty, Chandra, Roy & Kar, 1977) . This, and the implantation and development to healthy fetuses of 'tube-locked' embryos after transfer to foster mothers observed in this study, suggests that centchroman acts by alteration of genital tract function and not by a direct cytotoxic effect. Embryos recovered from rats treated with certain other non-steroidal antioestrogens, such as tamoxifen (Walpole, 1968) , clomiphene (Staples, 1966) , U-l 1100A and U-l 1555A (Duncan & Forbes, 1965) , retain the ability to develop in foster mothers. The different effect of centchroman in mice needs be to investigated in rats. The tests with unilaterally pregnant recipient mice in this study demonstrated that the post-implan¬ tation résorption of embryos from centchroman-treated females is not due to the lack of a sustained luteotrophic stimulus. It is well established that, in the mouse, ovaries are required throughout the period of gestation (Rubinstein & Forbes, 1963) .
Centchroman administered to pregnant mice and rabbits during the period of organogénesis does not cause any congenital anomalies (Sethi, 1977) , and the normality of those embryos that did develop from mice treated with centchroman during the preimplantation stages is encouraging.
